Differences in human macrophage receptor usage, lysosomal fusion kinetics and survival between logarithmic and metacyclic Leishmania infantum chagasi promastigotes

被引:34
作者
Ueno, Norikiyo [1 ]
Bratt, Carol L. [1 ]
Rodriguez, Nilda E. [2 ,4 ]
Wilson, Mary E. [1 ,2 ,3 ,4 ]
机构
[1] Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA
[2] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA
[3] Univ Iowa, Dept Epidemiol, Iowa City, IA USA
[4] Univ Iowa, VA Med Ctr, Iowa City, IA USA
关键词
HUMAN MONONUCLEAR PHAGOCYTES; PHLEBOTOMINE SAND FLIES; MANNOSE RECEPTOR; DENDRITIC CELLS; SURFACE LIPOPHOSPHOGLYCAN; INTRACELLULAR PARASITISM; COMPLEMENT RESISTANCE; VIANNIA BRAZILIENSIS; INFECTIVE STAGE; HOST-DEFENSE;
D O I
10.1111/j.1462-5822.2009.01374.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The obligate intracellular protozoan, Leishmania infantum chagasi (Lic) undergoes receptor-mediated phagocytosis by macrophages followed by a transient delay in phagolysosome maturation. We found differences in the pathway through which virulent Lic metacyclic promastigotes or avirulent logarithmic promastigotes are phagocytosed by human monocyte-derived macrophages (MDMs). Both logarithmic and metacyclic promastigotes entered MDMs through a compartment lined by the third complement receptor (CR3). In contrast, many logarithmic promastigotes entered through vacuoles lined by mannose receptors (MR) whereas most metacyclic promastigotes did not (P < 0.005). CR3-positive vacuoles containing metacyclic promastigotes stained for caveolin-1 protein, suggesting CR3 localizes in caveolae during phagocytosis. Following entry, the kinetics of phagolysosomal maturation and intracellular survival also differed. Vacuoles containing metacyclic parasites did not accumulate lysosome-associated membrane protein-1 (LAMP-1) at early times after phagocytosis, whereas vacuoles with logarithmic promastigotes did. MDMs phagocytosed greater numbers of logarithmic than metacyclic promastigotes, yet metacyclics ultimately replicated intracellularly with greater efficiency. These data suggest that virulent metacyclic Leishmania promastigotes fail to ligate macrophage MR, and enter through a path that ultimately enhances intracellular survival. The relatively quiescent entry of virulent Leishmania spp. into macrophages may be accounted for by the ability of metacyclic promastigotes to selectively bypass deleterious entry pathways.
引用
收藏
页码:1827 / 1841
页数:15
相关论文
共 56 条
  • [1] Mechanisms of phagocytosis in macrophages
    Aderem, A
    Underhill, DM
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, 1999, 17 : 593 - 623
  • [2] The role of mannose receptor during experimental leishmaniasis
    Akilov, Oleg E.
    Kasuboski, Rachel E.
    Carter, Cristina R.
    McDowell, Mary Ann
    [J]. JOURNAL OF LEUKOCYTE BIOLOGY, 2007, 81 (05) : 1188 - 1196
  • [3] Alexander J, 1999, J CELL SCI, V112, P2993
  • [4] THE INTERACTION OF LEISHMANIA SPECIES WITH MACROPHAGES
    ALEXANDER, J
    [J]. ADVANCES IN PARASITOLOGY, 1992, 31 : 175 - 254
  • [5] From pattern recognition receptor to regulator of homeostasis: The double-faced macrophage mannose receptor
    Allavena, P
    Chieppa, M
    Monti, P
    Piemonti, L
    [J]. CRITICAL REVIEWS IN IMMUNOLOGY, 2004, 24 (03) : 179 - 192
  • [6] Allen Lee-Ann H., 2007, V412, P273, DOI 10.1007/978-1-59745-467-4_18
  • [7] METACYCLOGENESIS OF LEISHMANIA SPP - SPECIES-SPECIFIC INVITRO TRANSFORMATION, COMPLEMENT RESISTANCE, AND CELL-SURFACE CARBOHYDRATE AND PROTEIN PROFILES
    BANDYOPADHYAY, P
    GHOSH, DK
    DE, A
    GHOSH, KN
    CHAUDHURI, PP
    DAS, P
    BHATTACHARYA, A
    [J]. JOURNAL OF PARASITOLOGY, 1991, 77 (03) : 411 - 416
  • [8] SIMPLE MONOPHASIC MEDIUM FOR AXENIC CULTURE OF HEMOFLAGELLATES
    BERENS, RL
    BRUN, R
    KRASSNER, SM
    [J]. JOURNAL OF PARASITOLOGY, 1976, 62 (03) : 360 - 365
  • [9] MACROPHAGE COMPLEMENT AND LECTIN-LIKE RECEPTORS BIND LEISHMANIA IN THE ABSENCE OF SERUM
    BLACKWELL, JM
    EZEKOWITZ, RAB
    ROBERTS, MB
    CHANNON, JY
    SIM, RB
    GORDON, S
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1985, 162 (01) : 324 - 331
  • [10] BRITTINGHAM A, 1995, J IMMUNOL, V155, P3102